About this trial
Various spine surgeons perform wound irrigation using saline mixed with vancomycin, relying on mechanical debridement of non-viable tissue, physical disruption of biofilm, and bacteriostatic effect against gram positive flora. When used as a powder, topical application of vancomycin has demonstrated increased risk of symptomatic seroma formation, which is an adverse outcome that often requires bedside or intra-operative aspiration. Broad-spectrum antiseptic agents, such as Irrisept, offer bacteriocidal properties to eliminate hardware inoculation, thereby minimizing the risk of deep space infection, while obviating the risk of seroma development.
Eligibility criteria
Qualifiers
Age: 18+ years old
Indications: deformity, oncologic, degenerative, trauma
Standard layer-by-layer closure
Locoregional flap-based closure
Disqualifiers
Acute/chronic open wounds (spine or non-spine)
On-going non-spinal infection within 30 days of index operation
Concurrent antibiotic use (for spine or non-spine infections)
History of prior spinal infection
Trial design
Treatments tested in this trial
- Chlorhexidine gluconate solution
- Vancomycin